Published in Lancet Infect Dis on May 01, 2006
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01
Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis (2008) 3.92
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med (2008) 2.77
Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis (2013) 2.29
Microbial interactions during upper respiratory tract infections. Emerg Infect Dis (2008) 2.18
Major issues and challenges of influenza pandemic preparedness in developing countries. Emerg Infect Dis (2008) 2.16
A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis (2010) 2.09
Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J Infect Dis (2012) 1.95
Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health (2008) 1.88
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis (2011) 1.87
Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe (2011) 1.86
Key transmission parameters of an institutional outbreak during the 1918 influenza pandemic estimated by mathematical modelling. Theor Biol Med Model (2006) 1.72
Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis (2013) 1.55
Augmented lung inflammation protects against influenza A pneumonia. PLoS One (2009) 1.47
The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions. PLoS One (2012) 1.47
Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med (2013) 1.35
Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect (2012) 1.30
Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis (2008) 1.30
Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies. BMC Med (2009) 1.29
Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis (2012) 1.24
Pathogenic responses among young adults during the 1918 influenza pandemic. Emerg Infect Dis (2012) 1.22
The impact of successive infections on the lung microenvironment. Immunology (2007) 1.21
Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol (2012) 1.21
Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis (2011) 1.19
Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis (2013) 1.16
Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis (2010) 1.11
Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10
A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol (2008) 1.07
Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis (2007) 1.04
Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care (2011) 1.01
A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. Am J Pathol (2009) 0.99
Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health (2011) 0.96
The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis (2014) 0.93
Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia. EMBO Mol Med (2014) 0.93
Haemophilus influenzae and the lung (Haemophilus and the lung). Clin Transl Med (2012) 0.91
Macrophage-mediated inflammation and disease: a focus on the lung. Mediators Inflamm (2012) 0.91
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol (2011) 0.91
Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol (2014) 0.90
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. Int J Chron Obstruct Pulmon Dis (2007) 0.90
Respiratory Infections in the U.S. Military: Recent Experience and Control. Clin Microbiol Rev (2015) 0.90
Detection of respiratory viruses by PCR assay of nasopharyngeal swabs stored in skim milk-tryptone-glucose-glycerol transport medium. J Clin Microbiol (2011) 0.90
Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors. Proc Natl Acad Sci U S A (2014) 0.89
Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip Perspect Infect Dis (2011) 0.88
Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae. Clin Vaccine Immunol (2013) 0.87
Successive influenza virus infection and Streptococcus pneumoniae stimulation alter human dendritic cell function. BMC Infect Dis (2011) 0.87
Epidemiological isolation causing variable mortality in Island populations during the 1918-1920 influenza pandemic. Influenza Other Respir Viruses (2012) 0.86
Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles. Epidemiol Infect (2011) 0.86
Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics (2009) 0.85
The open-air treatment of pandemic influenza. Am J Public Health (2009) 0.85
Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine (2011) 0.84
Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis (2013) 0.84
Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol (2012) 0.84
The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi). J Immunol Res (2015) 0.83
Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. BMC Infect Dis (2010) 0.83
Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae. J R Soc Interface (2013) 0.83
Nonpharmaceutical Interventions for Military Populations During Pandemic Influenza. Turk Silahli Kuvvetleri Koruyucu Hekim Bul (2007) 0.83
The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses (2016) 0.82
Excess Mortality Associated with Influenza among Tuberculosis Deaths in South Africa, 1999-2009. PLoS One (2015) 0.82
The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspective. Evol Med Public Health (2016) 0.82
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008. BMC Infect Dis (2015) 0.81
Unveiling the burden of influenza-associated pneumococcal pneumonia. J Infect Dis (2011) 0.81
Evaluation of swabbing methods for estimating the prevalence of bacterial carriage in the upper respiratory tract: a cross sectional study. BMJ Open (2014) 0.81
The complex link between influenza and severe sepsis. Virulence (2013) 0.81
MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway. Am J Physiol Lung Cell Mol Physiol (2015) 0.81
The impact of coinfections and their simultaneous transmission on antigenic diversity and epidemic cycling of infectious diseases. Biomed Res Int (2014) 0.81
Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012. Vaccine (2015) 0.81
High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice. Sci Rep (2012) 0.80
Detection of viral and bacterial pathogens in hospitalized children with acute respiratory illnesses, Chongqing, 2009-2013. Medicine (Baltimore) (2015) 0.80
Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. Hum Vaccin Immunother (2013) 0.80
Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Eur J Immunol (2014) 0.80
Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models. Proc Biol Sci (2013) 0.80
A comparative study of thin-section CT findings between seasonal influenza virus pneumonia and Streptococcus pneumoniae pneumonia. Br J Radiol (2014) 0.80
The association of meningococcal disease with influenza in the United States, 1989-2009. PLoS One (2014) 0.79
Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health (2012) 0.79
Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ. J Immunol (2013) 0.79
Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review. PLoS One (2015) 0.79
Cost-effectiveness of pneumococcal polysaccharide vaccine among healthcare workers during an influenza pandemic. Am J Manag Care (2010) 0.79
Mailed versus frozen transport of nasal swabs for surveillance of respiratory bacteria in remote Indigenous communities in Australia. BMC Infect Dis (2013) 0.78
Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection. BMC Genomics (2013) 0.78
The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections. Front Microbiol (2016) 0.78
Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study. PLoS One (2015) 0.78
Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. MBio (2016) 0.77
A Case of Severe Pseudomembranous Tracheobronchitis Complicated by Co-infection of Influenza A (H1N1) and Staphylococcus aureus in an Immunocompetent Patient. Tuberc Respir Dis (Seoul) (2015) 0.76
A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza. Sci Rep (2016) 0.76
Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza. J Pharmacokinet Pharmacodyn (2016) 0.76
Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease? Eur J Clin Microbiol Infect Dis (2013) 0.76
Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One (2014) 0.76
The role of influenza in the epidemiology of pneumonia. Sci Rep (2015) 0.76
Temporal cross-correlation between influenza-like illnesses and invasive pneumococcal disease in the Netherlands. Influenza Other Respir Viruses (2016) 0.75
Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome. PLoS One (2016) 0.75
Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza. MBio (2016) 0.75
Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona. BMC Infect Dis (2016) 0.75
NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase. J Virol (2016) 0.75
Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia. Biomed Res Int (2016) 0.75
Utility of Keywords from Chest Radiograph Reports for Pneumonia Surveillance Among Hospitalized Patients with Influenza: The CDC Influenza Hospitalization Surveillance Network, 2008-2009. Public Health Rep (2016) 0.75
Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis (2016) 0.75
Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality. Yale J Biol Med (2017) 0.75
Secondary Bacterial Infections Associated with Influenza Pandemics. Front Microbiol (2017) 0.75